A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignancies
Sauter, Craig S., Chou, Joanne F., Papadopoulos, Esperanza B., Perales, Miguel-Angel, Jakubowski, Ann A., Young, James W., Scordo, Michael, Giralt, Sergio, Castro-Malaspina, HugoVolume:
55
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2014.894185
Date:
December, 2014
File:
PDF, 253 KB
english, 2014